Clinical Trial Results:
Doppelblinde, prospektiv-randomisierte, intraindividuell-halbseitenvergleichende Studie zur klinischen Wirksamkeit von Verrumal® Lsg. bei aktinischen Keratosen gegen Vehikel: Investigator-initiierte “Proof-of-Concept“-Studie
Doubleblind, prospective-randomised, intraindividuell-halfsite-comparing study regarding the clinical efficacy of Verrumal in the treatment of actinic keratosis vs. placebo: investigator-initiated proof-of-concept study
Summary
|
|
EudraCT number |
2006-005034-20 |
Trial protocol |
DE |
Global completion date |
03 Nov 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
02 Feb 2020
|
First version publication date |
02 Feb 2020
|
Other versions |
|
Summary report(s) |
2006-005034-20 Verrumal_Synopsis 06_2009 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.